Get emailed when EXAS changes direction
Insider selling: $2,362,397 sold by 18 insiders (30d)
Est. revisions:
+114.3%
(1 up, 1 down in 30d)
Backed by structured data (insider trades, analyst ratings, or filings)
Factor Model (net +1.9)
Factor Model
net +1.9 3.6 / 10
Est. Revisions
+1.0
Insider Activity
+0.0
Momentum
+0.1
Analyst Rev.
+0.0
Narrative Gap
+0.0
Abbott acquisition cleared with 99.7% shareholder vote
Watch: Monitor for any remaining regulatory challenges (primarily FDA or antitrust) and management commentary on deal closing timeline. Completion likely in mid-2026.
Abbott's $21 billion acquisition of Exact Sciences won overwhelming shareholder approval on February 20, 2026, with 99.7% voting in favor (128.4 million votes for, 0.4 million against). Abbott will pay $105 per share in cash. The deal still needs customary closing conditions and regulatory approvals to finalize.
This clears the last major shareholder hurdle. The deal is now in the final stretch — regulatory approvals and standard closing mechanics are the remaining gates. EXAS shareholders locked in $105/share; deal completion is a matter of timing, not debate.
Evidence
8d ago
Jim Cramer Says Abbot Is “Going to Have to Give Us a Couple of Reasons on the Call” to Go Higher
yahoo-finance
9d ago
Insider buy by CONROY KEVIN T (EXAS): $1,001,325
27d ago
Abbott Laboratories (ABT) Announces Completion of Acquisition of Exact Sciences
yahoo-finance
46d ago
Soros 13F (2025Q4):. New position in JAZZ INVESTMENTS I LTD ($173,176,300) +128
48d ago
Exact Sciences (EXAS) Merger with Abbott Moving Forward After Shareholder Approval
yahoo-finance
52d ago
Exact Sciences (EXAS) Merger with Abbott Moving Forward After Shareholder Approval
yahoo-finance
Fundamentals & Data ▾
Exact Sciences Corp
Healthcare · Diagnostics & Research
Mkt Cap
$20B
Beta
1.44
52w Range
$38.81 - $104.98
Short Interest
7.4M 3.92%
Days to Cover
3.2 +11%
Technicals
uptrend
vs 20d MA
+0.1%
vs 50d MA
+0.9%
from 52w Hi
0.0%
Vol (20d)
2%
1w return
+0.1%
1m return
+1.2%
3m return
+2.2%
Vol ratio
1.0x
Insiders
selling
0B / 9S
EPS Estimate
$0.05
+114.3% 30d
1up / 1dn
Est. Dispersion
0%
1 analysts
Analyst Target
$106
$105 - $118
Insider Cluster
strong sell
1B / 10S (officer)
Fund Convergence
strong
Renaissance, D.E. Shaw, Soros, Citadel, Two Sigma
Financials
Revenue
$878M +23% YoY
FCF
$120M
Gross Margin
70%
Op Margin
-9%
Momentum:
decelerating
Top Holders
Renaissance
$162M
D.E. Shaw
$146M
Soros
$88M
Citadel
$56M
Two Sigma
$1M
Recent Filings & Data
insider trade
103
net selling
· $2,362,397 sold
· $1,001,325 bought
18 insiders · 103 transactions (30d)
Recent transactions
ORVILLE JACOB A · other
HERRIOTT JAMES · other
CONDELLA SARAH K · award
BARANICK BRIAN · award
BLOOMER AARON · award
ORVILLE JACOB A · award
CONROY KEVIN T · award
CONROY KEVIN T · other
CONDELLA SARAH K · exercise · $19,617
CONROY KEVIN T · award
BARANICK BRIAN · award
CONDELLA SARAH K · award
HERRIOTT JAMES · award
ORVILLE JACOB A · award
CONROY KEVIN T · award
CONDELLA SARAH K · other
BARANICK BRIAN · other
HERRIOTT JAMES · other
BLOOMER AARON · other
ORVILLE JACOB A · sell · $375,000
HERRIOTT JAMES · sell · $70,000
BARANICK BRIAN · sell · $200,289
HERRIOTT JAMES · sell · $105,120
ZANOTTI KATHERINE S · sell · $780,000
DOYLE JAMES EDWARD · sell · $120,000
HERRIOTT JAMES · sell · $90,000
DOYLE JAMES EDWARD · sell · $62,400
ORVILLE JACOB A · other
BARANICK BRIAN · other
ZANOTTI KATHERINE S · sell · $170,612
BARBER MICHAEL J · award
POPOVITS KIMBERLY J · award
ZANOTTI KATHERINE S · award
CLANCY PAUL J. · award
DOYLE JAMES EDWARD · award
PETROVIC SHACEY · award
LEVANGIE DANIEL J · award
COWARD DAVID SCOTT · award
TRIGG LESLIE L · award
HERRIOTT JAMES · award · $13,888
TRIGG LESLIE L · award
BLOOMER AARON · other
CONROY KEVIN T · exercise · $1,493,261
CONDELLA SARAH K · other
ORVILLE JACOB A · other
CONROY KEVIN T · other
CONDELLA SARAH K · other
BARANICK BRIAN · other
HERRIOTT JAMES · other
ORVILLE JACOB A · other
CONROY KEVIN T · other
CONDELLA SARAH K · other
BARANICK BRIAN · other
HERRIOTT JAMES · other
CONDELLA SARAH K · award
BARANICK BRIAN · award
HERRIOTT JAMES · award
ORVILLE JACOB A · award
CONROY KEVIN T · award
COWARD DAVID SCOTT · other
ORVILLE JACOB A · other
CONROY KEVIN T · other
CONDELLA SARAH K · other
BARANICK BRIAN · other
POPOVITS KIMBERLY J · award
CONROY KEVIN T · buy · $1,001,325
BARANICK BRIAN · sell · $65,030
BARANICK BRIAN · other
BARBER MICHAEL J · award
BARBER MICHAEL J · award
ZANOTTI KATHERINE S · award
ZANOTTI KATHERINE S · award
CLANCY PAUL J. · award
CLANCY PAUL J. · award
DOYLE JAMES EDWARD · award
DOYLE JAMES EDWARD · award
PETROVIC SHACEY · award
PETROVIC SHACEY · award
SEBELIUS KATHLEEN G · award
SEBELIUS KATHLEEN G · award
LEVANGIE DANIEL J · award
LEVANGIE DANIEL J · award
COWARD DAVID SCOTT · award
COWARD DAVID SCOTT · award
CONROY KEVIN T · other
ELLIOTT JEFFREY THOMAS · sell · $8,180
CONDELLA SARAH K · sell · $6,135
CONROY KEVIN T · sell · $69,473
CUNNINGHAM EVERETT V · sell · $8,180
ORVILLE JACOB A · sell · $6,135
BARANICK BRIAN · sell · $6,616
HERRIOTT JAMES · sell · $1,804
COWARD DAVID SCOTT · sell · $4,030
ELLIOTT JEFFREY THOMAS · award · $41,960
CONDELLA SARAH K · award · $42,020
BARANICK BRIAN · award
HERRIOTT JAMES · award · $42,020
CUNNINGHAM EVERETT V · award · $42,020
COWARD DAVID SCOTT · award
ORVILLE JACOB A · award
CONROY KEVIN T · award · $42,020
BARANICK BRIAN · sell · $73,393
CONDELLA SARAH K · sell · $140,000
7 signals · latest 6d ago
Get alerted when EXAS changes direction
We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.